Owlstone Medical Secures Funding for Breath-Based Diagnostics
April 26, 2024, 3:31 pm
Imperial College London
Location: United Kingdom, England, Westminster
Employees: 5001-10000
Founded date: 2014
Total raised: $1.31M
University of Cape Town
Location: South Africa, Western Cape, Cape Town
Employees: 1001-5000
Founded date: 1829
Bill & Melinda Gates Foundation
Location: United States, Washington, Seattle
Employees: 1001-5000
Founded date: 2000
Owlstone Medical, a UK-based company specializing in Breath Biopsy® for early disease detection, secured $6.5 million in funding. The funding includes a $5 million equity investment and a $1.5 million grant from the Bill & Melinda Gates Foundation. This marks the foundation's first equity position in a breath diagnostics company. The funding will support the development of breath-based diagnostic solutions for tuberculosis (TB) and HIV, with a focus on improving outcomes in the developing world. Owlstone aims to identify VOC biomarkers for TB and HIV detection, expanding their Breath Biopsy VOC Atlas database. Led by CEO Billy Boyle, Owlstone is dedicated to transforming infectious disease diagnosis through innovative technology.